1-8 of 8
Qiang Wang
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

A Randomized, Open-Label, Multicenter, Phase 3 Study of High-Dose Vitamin C Plus FOLFOX ± Bevacizumab versus FOLFOX ± Bevacizumab in Unresectable Untreated Metastatic Colorectal Cancer (VITALITY Study)

Feng Wang, Ming-Ming He, Jian Xiao, Yan-Qiao Zhang, Xiang-Lin Yuan, Wei-Jia Fang, Yan Zhang, Wei Wang, Xiao-Hua Hu, Zhi-Gang Ma, Yi-Chen Yao, Zhi-Xiang Zhuang, Fu-Xiang Zhou, Jie-Er Ying, Ying Yuan, Qing-Feng Zou, Zeng-Qing Guo, Xiang-Yuan Wu, Ying Jin, Zong-Jiong Mai, Zhi-Qiang Wang, Hong Qiu, Ying Guo, Si-Mei Shi, Shuang-Zhen Chen, Hui-Yan Luo, Dong-Sheng Zhang, Feng-Hua Wang, Yu-Hong Li, Rui-Hua Xu
Journal: Clinical Cancer Research
Clin Cancer Res (2022) 28 (19): 4232–4239.
https://doi.org/10.1158/1078-0432.CCR-22-0655
Published: 03 October 2022
View article titled, A Randomized, Open-Label, Multicenter, Phase 3 Study of High-Dose Vitamin C Plus FOLFOX ± Bevacizumab versus FOLFOX ± Bevacizumab in Unresectable Untreated Metastatic Colorectal Cancer (VITALITY Study)
Open the PDF for A Randomized, Open-Label, Multicenter, Phase 3 Study of High-Dose Vitamin C Plus FOLFOX ± Bevacizumab versus FOLFOX ± Bevacizumab in Unresectable Untreated Metastatic Colorectal Cancer (VITALITY Study) in another window
Includes: Supplementary data
Journal Articles

Nuclear–Cytoplasmic Transport Is a Therapeutic Target in Myelofibrosis

Dongqing Yan, Anthony D. Pomicter, Srinivas Tantravahi, Clinton C. Mason, Anna V. Senina, Jonathan M. Ahmann, Qiang Wang, Hein Than, Ami B. Patel, William L. Heaton, Anna M. Eiring, Phillip M. Clair, Kevin C. Gantz, Hannah M. Redwine, Sabina I. Swierczek, Brayden J. Halverson, Erkan Baloglu, Sharon Shacham, Jamshid S. Khorashad, Todd W. Kelley, Mohamed E. Salama, Rodney R. Miles, Kenneth M. Boucher, Josef T. Prchal, Thomas O'Hare, Michael W. Deininger
Journal: Clinical Cancer Research
Clin Cancer Res (2019) 25 (7): 2323–2335.
https://doi.org/10.1158/1078-0432.CCR-18-0959
Published: 01 April 2019
View article titled, Nuclear–Cytoplasmic Transport Is a Therapeutic Target in Myelofibrosis
Open the PDF for Nuclear–Cytoplasmic Transport Is a Therapeutic Target in Myelofibrosis in another window
Includes: Supplementary data
Journal Articles

The RNA-binding Protein MEX3B Mediates Resistance to Cancer Immunotherapy by Downregulating HLA-A Expression

Lu Huang, Shruti Malu, Jodi A. McKenzie, Miles C. Andrews, Amjad H. Talukder, Trang Tieu, Tatiana Karpinets, Cara Haymaker, Marie-Andrée Forget, Leila J. Williams, Zhe Wang, Rina M. Mbofung, Zhi-Qiang Wang, Richard Eric Davis, Roger S. Lo, Jennifer A. Wargo, Michael A. Davies, Chantale Bernatchez, Timothy Heffernan, Rodabe N. Amaria, Anil Korkut, Weiyi Peng, Jason Roszik, Gregory Lizée, Scott E. Woodman, Patrick Hwu
Journal: Clinical Cancer Research
Series: Author Choice
Clin Cancer Res (2018) 24 (14): 3366–3376.
https://doi.org/10.1158/1078-0432.CCR-17-2483
Published: 15 July 2018
View article titled, The RNA-binding Protein MEX3B Mediates Resistance to Cancer Immunotherapy by Downregulating HLA-A Expression
Open the PDF for The RNA-binding Protein MEX3B Mediates Resistance to Cancer Immunotherapy by Downregulating HLA-A Expression in another window
Includes: Supplementary data
Journal Articles

CD103 and Intratumoral Immune Response in Breast Cancer

Zhi-Qiang Wang, Katy Milne, Heather Derocher, John R. Webb, Brad H. Nelson, Peter H. Watson
Journal: Clinical Cancer Research
Series: Author Choice
Clin Cancer Res (2016) 22 (24): 6290–6297.
https://doi.org/10.1158/1078-0432.CCR-16-0732
Published: 15 December 2016
View article titled, CD103 and Intratumoral Immune Response in Breast Cancer
Open the PDF for CD103 and Intratumoral Immune Response in Breast Cancer in another window
Includes: Supplementary data
Journal Articles

EGFR Fluorescence In situ Hybridization Pattern of Chromosome 7 Disomy Predicts Resistance to Cetuximab in KRAS Wild-type Metastatic Colorectal Cancer Patients

Yu-Hong Li, Fang Wang, Lin Shen, Yan-Ming Deng, Qiong Shao, Fen Feng, Xin An, Feng-Hua Wang, Zhi-Qiang Wang, Rui-Hua Xu, Jian-Yong Shao
Journal: Clinical Cancer Research
Clin Cancer Res (2011) 17 (2): 382–390.
https://doi.org/10.1158/1078-0432.CCR-10-0208
Published: 16 January 2011
View article titled, <em>EGFR</em> Fluorescence <em>In situ</em> Hybridization Pattern of Chromosome 7 Disomy Predicts Resistance to Cetuximab in KRAS Wild-type Metastatic Colorectal Cancer Patients
Open the PDF for <em>EGFR</em> Fluorescence <em>In situ</em> Hybridization Pattern of Chromosome 7 Disomy Predicts Resistance to Cetuximab in KRAS Wild-type Metastatic Colorectal Cancer Patients in another window
Includes: Supplementary data
Journal Articles

In vivo Imaging of Oral Mucositis in an Animal Model Using Optical Coherence Tomography and Optical Doppler Tomography

Petra Wilder-Smith, Marie J. Hammer-Wilson, Jun Zhang, Qiang Wang, Kathryn Osann, Zhongping Chen, Harvey Wigdor, Joel Schwartz, Joel Epstein
Journal: Clinical Cancer Research
Clin Cancer Res (2007) 13 (8): 2449–2454.
https://doi.org/10.1158/1078-0432.CCR-06-2234
Published: 16 April 2007
View article titled, <em>In vivo</em> Imaging of Oral Mucositis in an Animal Model Using Optical Coherence Tomography and Optical Doppler Tomography
Open the PDF for <em>In vivo</em> Imaging of Oral Mucositis in an Animal Model Using Optical Coherence Tomography and Optical Doppler Tomography in another window
Journal Articles

Dose-Ranging Study of the Safety and Pharmacokinetics of Atrasentan in Patients with Refractory Malignancies

Christopher W. Ryan, Nicholas J. Vogelzang, Everett E. Vokes, Hedy L. Kindler, Samir D. Undevia, Rod Humerickhouse, Amy K. André, Qiang Wang, Robert A. Carr, Mark J. Ratain
Journal: Clinical Cancer Research
Clin Cancer Res (2004) 10 (13): 4406–4411.
https://doi.org/10.1158/1078-0432.CCR-04-0083
Published: 06 July 2004
View article titled, Dose-Ranging Study of the Safety and Pharmacokinetics of Atrasentan in Patients with Refractory Malignancies
Open the PDF for Dose-Ranging Study of the Safety and Pharmacokinetics of Atrasentan in Patients with Refractory Malignancies in another window
Journal Articles

Tumor Necrosis Factor-α-promoted Expression of Bcl-2 and Inhibition of Mitochondrial Cytochrome c Release Mediate Resistance of Mature Dendritic Cells to Melanoma-induced Apoptosis

Clemens Esche, Galina V. Shurin, John M. Kirkwood, Gui-Qiang Wang, Hannah Rabinowich, Georgi Pirtskhalaishvili, Michael R. Shurin
Journal: Clinical Cancer Research
Clin Cancer Res (2001) 7 (3): 974s–979s.
Published: 01 March 2001
View article titled, Tumor Necrosis Factor-α-promoted Expression of Bcl-2 and Inhibition of Mitochondrial Cytochrome <em>c</em> Release Mediate Resistance of Mature Dendritic Cells to Melanoma-induced Apoptosis
Open the PDF for Tumor Necrosis Factor-α-promoted Expression of Bcl-2 and Inhibition of Mitochondrial Cytochrome <em>c</em> Release Mediate Resistance of Mature Dendritic Cells to Melanoma-induced Apoptosis in another window